These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 1699277

  • 1. Fludarabine phosphate--looking forward.
    Cheson BD.
    Semin Oncol; 1990 Oct; 17(5 Suppl 8):1-2. PubMed ID: 1699277
    [No Abstract] [Full Text] [Related]

  • 2. Fludarabine phosphate: an effective therapy for lymphoid malignancies.
    Semin Oncol; 1990 Oct; 17(5 Suppl 8):1-78. PubMed ID: 1699278
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Fludarabine shows promise for some leukemia patients.
    Oncology (Williston Park); 1989 Mar; 3(3):14. PubMed ID: 2484283
    [No Abstract] [Full Text] [Related]

  • 7. Fludarabine phosphate in lymphoma: an important new therapeutic agent.
    McLaughlin P, Robertson LE, Keating MJ.
    Cancer Treat Res; 1996 Mar; 85():3-14. PubMed ID: 9043771
    [No Abstract] [Full Text] [Related]

  • 8. Fludarabine phosphate in the treatment of chronic lymphocytic leukemia: biology, clinical impact, and future directions.
    Robertson LE, Keating MJ.
    Cancer Treat Res; 1993 Mar; 64():105-19. PubMed ID: 7680874
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Fludarabine monophosphate: a potentially useful agent in chronic lymphocytic leukemia.
    Grever MR, Kopecky KJ, Coltman CA, Files JC, Greenberg BR, Hutton JJ, Talley R, Von Hoff DD, Balcerzak SP.
    Nouv Rev Fr Hematol (1978); 1988 Mar; 30(5-6):457-9. PubMed ID: 2464793
    [Abstract] [Full Text] [Related]

  • 14. [Phase I clinical study of SH L573 (fludarabine phosphate) in patients with chronic lymphocytic leukemia and adult T-cell leukemia/lymphoma].
    Arima N, Mizoguchi H, Shirakawa S, Tomonaga M, Takatsuki K, Ohno R.
    Gan To Kagaku Ryoho; 1999 Apr; 26(5):619-29. PubMed ID: 10234292
    [Abstract] [Full Text] [Related]

  • 15. Fludarabine phosphate therapy in other lymphoid malignancies.
    Kantarjian HM, Redman JR, Keating MJ.
    Semin Oncol; 1990 Oct; 17(5 Suppl 8):66-70. PubMed ID: 1699285
    [Abstract] [Full Text] [Related]

  • 16. Fludarabine-related hemolytic anemia in chronic lymphocytic leukemia and lymphoproliferative disorders.
    Taha HM, Narasihman P, Venkatesh L, Cawley M, Kaplan B.
    Am J Hematol; 1998 Dec; 59(4):316. PubMed ID: 9840913
    [No Abstract] [Full Text] [Related]

  • 17. Tumor lysis syndrome induced by fludarabine monophosphate: a case report.
    Nakhoul F, Green J, Abassi ZA, Carter A.
    Eur J Haematol; 1996 Apr; 56(4):254-5. PubMed ID: 8641396
    [No Abstract] [Full Text] [Related]

  • 18. Fludarabine in the treatment of lymphoproliferative malignancies.
    Feldman EJ, Keating MJ.
    Cancer Invest; 1993 Apr; 11(3):314-8. PubMed ID: 8485654
    [No Abstract] [Full Text] [Related]

  • 19. Treatment of advanced chronic lymphocytic leukemia by fludarabine. Results of a clinical phase-II study.
    Hiddemann W, Rottmann R, Wörmann B, Thiel A, Essink M, Ottensmeier C, Freund M, Büchner T, van de Loo J.
    Ann Hematol; 1991 Jul; 63(1):1-4. PubMed ID: 1715191
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.